According to AlphaMoat, in October 2026 DrugCard (drug-card.io) received 8,030 monthly visits (+25.2% MoM) — ranked #10,500 of 17,609 AI websites with traffic data, and #1,601 of 3,112 in Industry Services; its largest market is United States (35.1% of visits).
DrugCard is an AI pharmacovigilance tool providing automated literature screening and regulatory intelligence for drug-safety teams, streamlining daily pharmacovigilance workflows.
| Month | Monthly visits | MoM |
|---|---|---|
| 2025-11 | 5.4K | -24.4% |
| 2025-12 | 5.3K | -0.5% |
| 2026-01 | 4.1K | -22.6% |
| 2026-02 | 5.5K | +31.9% |
| 2026-03 | 5.2K | -5.5% |
| 2026-04 | 3.7K | -28.4% |
| 2026-05 | 5.6K | +51.1% |
| 2026-06 | 9.4K | +68.1% |
| 2026-07 | 9.9K | +5.6% |
| 2026-08 | 7.2K | -27.0% |
| 2026-09 | 6.4K | -11.4% |
| 2026-10 | 8.0K | +25.2% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, DrugCard (drug-card.io) received 8,030 visits (about 8.0K) in October 2026 (+25.2% month over month), ranking #10,500 of 17,609 AI websites with traffic data, and #1601 in Industry Services.
Over the last 12 months, DrugCard’s monthly visits went from 5.4K in November 2025 to 8.0K in October 2026 — up 49.4% overall; traffic peaked in July 2026 (9.9K).
In October 2026, DrugCard’s largest markets by share of visits are United States 35.1%, India 26.5%, UK 13.8%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.